Literature DB >> 9485012

Characterization of MAST9/Hevin, a SPARC-like protein, that is down-regulated in non-small cell lung cancer.

I Bendik1, P Schraml, C U Ludwig.   

Abstract

In the search for genes down-regulated in non-small cell lung cancer (NSCLC), we have identified a cDNA fragment, termed MAST9. Cloning, sequencing, and characterization of the full-length MAST9 cDNA revealed that the entire 2808 nucleotide sequence had an open reading frame of 1992 nucleotides encoding a Mr 75,000 protein. Sequence analysis disclosed a striking homology to SPARC, known to be involved in tumorigenesis. The recently identified "Hevin" cDNA isolated from high endothelial venules is identical to MAST9. Using Northern and Western blot analysis, we showed that MAST9 was down-regulated in the tumor samples of nine non-small cell lung carcinoma patients. Furthermore, we demonstrated that both the bacterially expressed and the endogenous MAST9 proteins form homodimers. The lack of expression in non-small cell lung carcinomas and its homology to SPARC suggest a putative role of MAST9 in lung tumor formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9485012

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Localization of the extracellular matrix protein SC1 to synapses in the adult rat brain.

Authors:  Starlee Lively; Maurice J Ringuette; Ian R Brown
Journal:  Neurochem Res       Date:  2006-12-07       Impact factor: 3.996

2.  SPARCL1: a potential molecule associated with tumor diagnosis, progression and prognosis of colorectal cancer.

Authors:  Hong Zhang; Emma Widegren; Da-Wei Wang; Xiao-Feng Sun
Journal:  Tumour Biol       Date:  2011-09-02

3.  Effect of hevin deletion in mice and characterization in trabecular meshwork.

Authors:  Min Hyung Kang; Dong-Jin Oh; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-06       Impact factor: 4.799

4.  SPARCL1 suppresses the proliferation and migration of human ovarian cancer cells via the MEK/ERK signaling.

Authors:  Yan Ma; Yuan Xu; Li Li
Journal:  Exp Ther Med       Date:  2018-08-07       Impact factor: 2.447

5.  SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells.

Authors:  G K Yiu; W Y Chan; S W Ng; P S Chan; K K Cheung; R S Berkowitz; S C Mok
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

6.  Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer.

Authors:  Irene Esposito; Hany Kayed; Shereen Keleg; Thomas Giese; E Helene Sage; Peter Schirmacher; Helmut Friess; Jörg Kleeff
Journal:  Neoplasia       Date:  2007-01       Impact factor: 5.715

7.  SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer.

Authors:  Shu-Jing Yu; Jie-Kai Yu; Wei-Ting Ge; Han-Guang Hu; Ying Yuan; Shu Zheng
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

8.  SPARCL1 suppresses metastasis in prostate cancer.

Authors:  Yuzhu Xiang; Qingchao Qiu; Ming Jiang; Renjie Jin; Brian D Lehmann; Douglas W Strand; Bojana Jovanovic; David J DeGraff; Yi Zheng; Dina A Yousif; Christine Q Simmons; Thomas C Case; Jia Yi; Justin M Cates; John Virostko; Xiusheng He; Xunbo Jin; Simon W Hayward; Robert J Matusik; Alfred L George; Yajun Yi
Journal:  Mol Oncol       Date:  2013-07-20       Impact factor: 6.603

9.  Expression of SPARC like protein 1 (SPARCL1), extracellular matrix-associated protein is down regulated in gastric adenocarcinoma.

Authors:  Aniruddha Jakharia; Biswajyoti Borkakoty; Sujay Singh
Journal:  J Gastrointest Oncol       Date:  2016-04

10.  Microarray-based cancer prediction using soft computing approach.

Authors:  Xiaosheng Wang; Osamu Gotoh
Journal:  Cancer Inform       Date:  2009-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.